Showing results (21-30 of 68) with videos related to
Sort By:
Pageof 7
Cancer Letters|June 30, 1990
Neuron specific enolase (NSE) in serum of patients with malignant melanomaE Wibe, E Paus, S AamdalEuropean Journal of Nuclear Medicine|January 1, 1986
Cerebral and cerebellar uptake of 99mTc-(d,1)-hexamethyl-propyleneamine oxime (HM-PAO) in patients with brain tumor studied by single photon emission computerized tomographyM W Lindegaard, A Skretting, B Hager, et al.British Journal of Cancer|August 1, 1991
Glomerular filtration rate, 131I-hippuran clearance and estimated creatinine clearance in cancer patientsM W Lindegaard, N Aass, E S Bue, et al.The Journal of Urology|December 1, 1990
Flutamide in hormone-resistant prostatic cancerS D Fosså, G Hosbach, E PausBritish Journal of Cancer|July 1, 1992
The prognostic significance of prostate specific antigen in metastatic hormone-resistant prostate cancerS D Fosså, H Waehre, E PausBritish Journal of Cancer|February 1, 1992
Neuron-specific enolase--a serum tumour marker in seminoma?S D Fosså, O Klepp, E PausTumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 11, 2000
Epitope mapping and affinity estimation of 83 antibodies against prostate-specific antigenE Paus, K Nustad, O P BørmerClinical Chemistry|April 28, 2001
Development of a rapid and sensitive immunofluorometric assay for glutathione S-transferase AL K Dajani, E Paus, D J WarrenEuropean Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Neuron-specific enolase as a prognostic factor in metastatic malignant melanomaE Wibe, E Hannisdal, E Paus, et al.Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1985
Intramuscular administration of hydroxyprogesterone caproate in patients with endometrial carcinoma. Pharmacokinetics and effects on adrenal functionM Onsrud, E Paus, E Haug, et al.Pageof 7